February 10-12, 2006 Hyatt Regency Hill Country Resort - San Antonio, TX Welcome • Program • Faculty Accreditation • Activities Accommodations • Registration Exhibitor Prospectus (in Adobe Acrobat Format)

Accreditation & Objectives

Statement of Need
Cardiovascular disease is the leading cause of morbidity and mortality in the United States. Evidence continues to emphasize the need to treat the risk factors that reduce CVD, including dyslipidemia, diabetes, the metabolic syndrome and obesity. Recent clinical trials have demonstrated that intensive management of dyslipidemia provides better cardiovascular outcomes; however, studies show that many patients do not attain their recommended goals. There is a need to provide healthcare providers with guidance and clarifi cation on current clinical dilemmas, as well as practical strategies to help optimize the outcomes of patients with lipid disorders.

Target Audience
This activity is designed to meet the educational needs of physicians, physician assistants, pharmacists, nurses and registered dietitians in the practice of lipid management.

Learning Objectives
NLA CME activities are intended to lead to better patient care. At the conclusion of this educational activity, participants will be better able to:

• Identify the constellation of cardiovascular risk markers in individuals with the metabolic syndrome.
• Review therapeutic options and emerging therapies for dyslipidemia, including low HDL and hypertriglyceridemia.
• Discuss the acute effects of exercise and dietary changes on lipid parameters.
• Identify implications of recent trials for clinical management of patients with acute coronary syndromes.
• Assess the outcome of characterization of dyslipoproteinemias by apoA and apoB containing lipoprotein subclasses and the methodology for their measurements.
• Discuss the use of advanced lipid testing in clinical risk assessment.
• Explain the application of antisense inhibition of apolipoprotein production.
• Recognize population differences in CRP levels that may impact clinical care.
• Describe the utilization of non-physician providers in CVD prevention and risk management in Hispanic and Native American populations.
• Implement novel interventions to reduce cardiovascular risk in special populations.
• Distinguish between real and spurious hepatotoxicity and myopathy in patients on lipid drugs.
• Incorporate coronary artery screening in practice to determine lipid goals.

CME credit provided by the National Lipid Association

Physicians
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) by the National Lipid Association. The National Lipid Association is accredited by the ACCME to provide continuing medical education for physicians.

The National Lipid Association designates this educational activity for a maximum of 10.5 category 1 credits toward the AMA Physician's Recognition Award. Each physician should claim only those credits that he/she actually spent in the activity.

Physician Assistants
AAPA accepts Category I credit from AOACCME, Prescribed credit from AAFP, and AMA Category I CME credit for the PRA from organizations accredited by ACCME.

CE credit provided by the Institute for Continuing Healthcare Education

Nurses
The Institute for Continuing Healthcare Education is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

This activity offers 12.7 contact hours to participating nurses. This credit may be applied toward licensure requirements in those states that recognize American Nurses Credentialing Center's Commission on Accreditation (ANCC-COA) accredited providers. Accreditation applies solely to educational activities and does not imply approval or endorsement of any commercial product by the ANCC-COA.

Susan R. Grady, RNC, MSN is the nurse planner for this activity.

Dietitians
This program is co-sponsored by the Institute for Continuing Healthcare Education and the National Lipid Association. The Institute for Continuing Healthcare Education, provider number IN003 is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR) from March 28, 2004 to March 27, 2007. Registered dietitians (RDs) and dietetic technicians, registered (DTRs) will receive 10.5 continuing professional education units (CPEUs) for completion of this Level 2 program. Continuing Professional Education Provider Accreditation does not constitute endorsement by the CDR of a provider, program, or materials.

Pharmacists
This program is co provided by the Institute for Continuing Healthcare Education and the National Lipid Association. The Institute for Continuing Healthcare Education is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is acceptable for 10.5 hours (1.05 CEUs) of continuing education credit in states that recognize ACPE–accredited providers (ACPE ID# 781-999-05-031-L04).

Criteria for Success
Certifi cates of completion will be awarded based on the participant's attendance, completion of registration form and evaluation form, and will be mailed within 4 weeks after the program.

NLA Medical CME Reviewer: Peter Jones, MD
SWLA 2006 Program Co-Chairs: Christie Ballantyne, MD and Darren McGuire, MD